Results 81 to 90 of about 74,008 (304)

Oral Azacitidine Maintenance After CPX‐351 in Transplant‐Ineligible Patients With Therapy‐Related or Myelodysplasia‐Related Acute Myeloid Leukemia

open access: yes
American Journal of Hematology, EarlyView.
Caroline Fileni   +18 more
wiley   +1 more source

Circulating tumor plasma cells quantification in newly diagnosed transplant ineligible real world multiple myeloma patients: Comparison of single‐platform flow cytometry versus next generation flow

open access: yesCytometry Part B: Clinical Cytometry, EarlyView.
Abstract Circulating tumor plasma cells (CTCs) at diagnosis are independent prognostic markers in newly diagnosed multiple myeloma (NDMM). Flow cytometry (FC) enables sensitive and cost‐effective CTC quantification, but prognostic cut‐offs vary across studies.
Elona Saraci   +30 more
wiley   +1 more source

Genetic and linguistic non-correspondence suggests evidence for collective social climbing in the Kol tribe of South Asia

open access: yesScientific Reports, 2020
Both classical and recent genetic studies have unanimously concluded that the genetic landscape of South Asia is unique. At long distances the ‘isolation-by-distance’ model appears to correspond well with the genetic data, whereas at short distances ...
Anshika Srivastava   +9 more
doaj   +1 more source

Animal genomes under the focus of cytogenetics

open access: yes, 2011
Decades before the recent advances in molecular biology and the knowledge of the complete nucleotide sequence of several genomes, cytogenetic analysis provided the first information concerning the genome organization. The exploration of molecular biology
Mazzuchelli, Juliana [UNESP]   +5 more
core  

Studies of fragile sites on human chromosome 16 / Julie Nancarrow. [PDF]

open access: yes, 1998
Copies of author's previously published articles inserted.Bibliography : leaves 194-222.vii, 231 leaves, [50] leaves of plates : ill. (chiefly col.) ; 30 cm.Thesis (Ph.D.)--University of Adelaide, Dept.
Nancarrow, Julie K.
core  

Old data, new tricks: Comprehensive computational analysis of 10 years of multi‐center EuroFlow acute myeloid leukemia diagnostic immunophenotypic data

open access: yesCytometry Part B: Clinical Cytometry, EarlyView.
Abstract Acute myeloid leukemia (AML) is characterized by high genotypic and immunophenotypic heterogeneity. We collected an extensive dataset containing 5366 flow cytometry files from 885 AML patients, stained with the EuroFlow acute leukemia orientation tube (ALOT) and AML/MDS panel, acquired in a standardized way at eight centers over a period of 10 
Sarah Bonte   +13 more
wiley   +1 more source

Clinical applications of CD34+ progenitor cell immunophenotyping in myelodysplastic neoplasms—The CytHem SMD French network experience

open access: yesCytometry Part B: Clinical Cytometry, EarlyView.
Abstract Myelodysplastic neoplasms (MDS) are clonal hematopoietic disorders characterized by ineffective hematopoiesis, peripheral cytopenias, and a risk of progression to acute myeloid leukemia. As the disease originates in hematopoietic stem and progenitor cells (HSPCs), flow cytometry (FCM) has emerged as a key approach to interrogate the bone ...
Nicolas Chapuis   +5 more
wiley   +1 more source

Un ravissant souvenir de mon stage chez le laboratoire de Jérôme Lejeune. A delightful memory from my stay at Jerôme Lejeune’s laboratory

open access: yesAnales de la Facultad de Medicina, 2016
For Number 2 of Volume 2 of AnFaMed we asked Prof. Máximo Drets to write a review article on the origins of clinical genetics and cytogenetics in Uruguay.
Máximo Drets
doaj   +2 more sources

Impact of cytogenetics on outcomes in pediatric acute lymphoblastic leukemia

open access: yes, 2018
Context: In acute lymphoblastic leukemia (ALL), the most important prognostic factors are age, leukocyte count at presentation, immunophenotype, and cytogenetic abnormalities.
Sadashivudu Gundeti   +5 more
core   +1 more source

Successful treatment of acute myelogenous leukemia with favorable cytogenetics by reduced-intensity stem cell transplantation [PDF]

open access: yes, 2010
Acute myelogenous leukemia (AML) with favorable cytogenetics responds well to chemotherapy. If the leukemia relapses, allogenic hematopoietic stem transplantation (allo-HSCT) is considered as a treatment option.
Takeda, Yukari   +19 more
core   +1 more source

Home - About - Disclaimer - Privacy